Phosphate toxicity: new insights into an old problem

被引:194
作者
Razzaque, M. Shawkat [1 ]
机构
[1] Harvard Univ, Sch Dent Med, Dept Oral Med Infect & Immun, Boston, MA 02115 USA
关键词
calcium; fibroblast growth factor 23 (FGF23); klotho; parathyroid hormone (PTH); sodium-dependent phosphate transporter; vitamin D; FIBROBLAST-GROWTH-FACTOR; SOFT-TISSUE CALCIFICATION; KLOTHO MUTANT MICE; VITAMIN-D; INORGANIC-PHOSPHATE; SEVERE HYPERPHOSPHATEMIA; BONE MINERALIZATION; TUMORAL CALCINOSIS; MISSENSE MUTATION; GENETIC-EVIDENCE;
D O I
10.1042/CS20100377
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Phosphorus is an essential nutrient required for critical biological reactions that maintain the normal homoeostatic control of the cell. This element is an important component of different cellular structures, including nucleic acids and cell membranes. Adequate phosphorus balance is vital for maintaining basic cellular functions, ranging from energy metabolism to cell signalling. In addition, many intracellular pathways utilize phosphate ions for important cellular reactions; therefore, homoeostatic control of phosphate is one of the most delicate biological regulations. Impaired phosphorus balance can affect the functionality of almost every human system, including musculoskeletal and cardiovascular systems, ultimately leading to an increase in morbidity and mortality of the affected patients. Human and experimental studies have found that delicate balance among circulating factors, like vitamin D, PTH (parathyroid hormone) and FGF23 (fibroblast growth factor 23), are essential for regulation of physiological phosphate balance. Dysregulation of these factors, either alone or in combination, can induce phosphorus imbalance. Recent studies have shown that suppression of the FGF23-klotho system can lead to hyperphosphataennia with extensive tissue damage caused by phosphate toxicity. The cause and consequences of phosphate toxicity will be briefly summarized in the present review.
引用
收藏
页码:91 / 97
页数:7
相关论文
共 79 条
[41]   Severe hyperphosphatemia and hypocalcemia following the rectal administration of a phosphate-containing Fleet® pediatric enema [J].
Marraffa, JM ;
Hui, A ;
Stork, CM .
PEDIATRIC EMERGENCY CARE, 2004, 20 (07) :453-456
[42]   FATAL POISONING FROM SODIUM-PHOSPHATE ENEMA - CASE-REPORT AND EXPERIMENTAL-STUDY [J].
MARTIN, RR ;
LISEHORA, GR ;
BRAXTON, M ;
BARCIA, PJ .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1987, 257 (16) :2190-2192
[43]   Identification of the human klotho gene and its two transcripts encoding membrane and secreted klotho protein [J].
Matsumura, Y ;
Aizawa, H ;
Shiraki-Iida, T ;
Nagai, R ;
Kuro-o, M ;
Nabeshima, Y .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1998, 242 (03) :626-630
[44]   FGF-23-Klotho signaling stimulates proliferation and prevents vitamin D-induced apoptosis [J].
Medici, Damian ;
Razzaque, Mohammed S. ;
DeLuca, Stephelynn ;
Rector, Trent L. ;
Hou, Bo ;
Kang, Kihwa ;
Goetz, Regina ;
Mohammadi, Moosa ;
Kuro-o, Makoto ;
Olsen, Bjorn R. ;
Lanske, Beate .
JOURNAL OF CELL BIOLOGY, 2008, 182 (03) :459-465
[45]   Inhibition of intestinal sodium-dependent inorganic phosphate transport by fibroblast growth factor 23 [J].
Miyamoto, K ;
Ito, M ;
Kuwahata, M ;
Kato, S ;
Segawa, H .
THERAPEUTIC APHERESIS AND DIALYSIS, 2005, 9 (04) :331-335
[46]   Molecular targets of hyperphosphataemia in chronic renal failure [J].
Miyamoto, KI ;
Ito, M ;
Segawa, H ;
Kuwahata, M .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2003, 18 :79-80
[47]   Structural basis for fibroblast growth factor receptor activation [J].
Mohammadi, M ;
Olsen, SK ;
Ibrahimi, OA .
CYTOKINE & GROWTH FACTOR REVIEWS, 2005, 16 (02) :107-137
[48]   FLUID AND SERUM ELECTROLYTE DISTURBANCES AS A COMPLICATION OF ENEMAS IN HIRSCHSPRUNGS DISEASE [J].
MOSELEY, PK ;
SEGAR, WE .
AMERICAN JOURNAL OF DISEASES OF CHILDREN, 1968, 115 (06) :714-&
[49]  
Murer H, 1998, KIDNEY INT, pS2
[50]   The discovery of α-Klotho and FGF23 unveiled new insight into calcium and phosphate homeostasis [J].
Nabeshima, Y. .
CELLULAR AND MOLECULAR LIFE SCIENCES, 2008, 65 (20) :3218-3230